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2Abstract
Background: Population ageing results in an increasing cancer burden in the elderly. We aimed to evaluate 
time-trends in cancer mortality for adults aged 65 and over for 17 major cancer-types and all cancer 
combined in 11 countries worldwide over the period 1970-2015.
Materials and Methods: We obtained cancer death certification and population figures from the WHO and 
PAHO databases. We computed age-standardized (world standard population) rates for individuals aged 65 
and over, and applied joinpoint regression models.
Results: Age-standardized mortality rates for all cancers combined showed a heterogeneous, but widespread 
decline. Lung cancer mortality rates have been decreasing among men, and increasing among women. 
Pancreatic cancer had unfavourable trends in all countries for both sexes. Despite variability across countries, 
other tobacco-related cancers (except kidney) showed overall favourable trends, except in Poland and Russia. 
Age-standardized mortality from stomach cancer has been declining in all countries for both sexes. Colorectal 
mortality has been declining, except in Poland and Russia. Liver cancer mortality increased in all countries, 
except in Japan, France and Italy, which had the highest rates in the past. Breast cancer mortality decreased 
for most countries, except for Japan, Poland and Russia. Trends for age-standardized uterine cancer rates in 
the USA, Canada and the UK were increasing over the last decade. Ovarian cancer rates showed declines in 
most countries. With the exception of Russia, prostate cancer rates showed overall declines. Lymphoid 
neoplasm rates have been declining in both sexes, except in Poland and Russia.
Conclusion: Over the last decades, age-standardized cancer mortality in the elderly has been decreasing in 
major countries worldwide and for major cancer sites, with the major exception of lung and uterine cancer 
in women and liver, pancreas and kidney cancers in both sexes. Cancer mortality for the elderly in Central 
and Eastern Europe remains comparatively high.
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3Key message: Age-standardized cancer mortality rates in the elderly decreased over the last two decades in 
major countries worldwide and for major cancer sites. Cancer of liver, pancreas and kidney, and in women 
lung and uterine cancer, and in general, Central and Eastern European countries showed higher mortality 
rates in recent years.
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4Introduction
In 2012, almost 50% of all new cancer cases globally were diagnosed among the elderly, defined as individuals 
aged 65 and more [1]. Worldwide absolute number of incidence cancers in the elderly are predicted to double 
in 2035 compared to 2012, reaching 14 million new cases [1].
Cancer mortality in the elderly began to decrease in the late 1980s and early 1990s in North America, several 
countries from Western Europe and Japan (women) [2-4]. However, systematic analyses of trends in the last 
two decades are not available.
Given the ageing of the population, and the different cancer rates and trends in various age groups, the public 
health impact of cancer in the elderly is of major interest and relevance. Moreover, cancer burden in the 
elderly strongly affects health care resources, and its growth represents a public health and clinical priority. 
We aim to analyse trends in cancer mortality in the elderly since 1970 in 11 countries worldwide.
Materials and Methods
From the World Health Organization (WHO) database (WHOSIS) [5], we obtained official death certification 
data for all cancers combined and 17 major cancer types: cancers of oral cavity and pharynx, esophagus, 
stomach, colorectum, liver, pancreas, larynx, lung, breast, uterus (WHO death certification data do not allow 
to distinguish between cervical and corpus uteri cancer), ovary, prostate, bladder, and kidney, as well as non-
Hodgkin lymphoma, multiple myeloma, and leukemia. We retrieved mortality figures for 11 major countries 
with over 20 million inhabitants and over 95% death certification coverage , i.e. the United States of America 
(USA), Canada, Argentina, Japan, Australia, the United Kingdom (UK), Germany, France, Italy, Poland and the 
Russian Federation over the period 1970-2015 (or the most recent available year). During the calendar 
periods considered three different Revisions of the International Classification of Diseases (ICD) were used 
(ICD 8 through 10) [6-8], which were recoded according to ICD-10 [8]. We obtained estimates of the resident 
population for the corresponding calendar periods, based on official censuses, from the WHO and, for the 
Americas, from the Pan American Health Organization (PAHO) databases [9].
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5We calculated age-specific mortality rates for each 5-year age group (from 65–69 to 80+ years for the USA 
and Canada, and up to 85+ for the other countries), as well as age-standardized rates (ASRs), using the world 
standard population [10].
To identify years in which changes in ASRs occurred, we applied joinpoint regression models [11], setting a 
maximum of 5 trend segments. We computed the estimated annual percent change (APC) for each of the 
trends identified by the joinpoint model and the overall average annual percent change (AAPC) [12, 13].
Results
Table 1 for men and Table 2 for women show age-standardized mortality rates per 100,000 elderly men and 
women, by cancer type and country, in the quinquennia 2000-2004 (2002) and 2010-2014 (2012), along with 
corresponding percent changes. Figure 1 (1a to 1f) and Supplement Tables S1 (men) and S2 (women) show 
results of the joinpoint analysis of age-standardized mortality rates, by cancer type and country.
All cancers
Age-standardized mortality trends in most recent periods were decreasing in all countries and more 
favourable in absolute terms in men than in women. Men in the USA and Canada had lower rates compared 
to the other countries. Joinpoint regression analysis shows favourable APCs in the last trend segment, ranged 
between -1% (Argentina) and -2% (Canada and France). Age-standardized rates in women were much lower 
compared to those of men. All countries showed falls in rates between 2002 and 2012 also for women, with 
Japan having the lowest rate.
In the following, we describe in detail the age-standardized trends for the four major cancers. Details on the 
other cancers included in the analysis are presented in the Appendix.
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6Colorectal cancer
Percent changes between 2002 and 2012 for men in Argentina, Poland and Russia were unfavourable. Age-
standardized trends from Japan and Germany decreased since around 1990. Rates for Poland steadily 
increased since 1972, reaching in 2012 the highest value (199.5/100,000). Russian mortality rates increased 
up to 2009, then plateaued, however, having the second highest rate of 173.9. The USA had the lowest age-
standardized mortality rate for men in 2012 with a value of 86.5 and the most favourable declining trend 
between 2002 and 2012. Women showed downward trends between 2002 and 2012 for all countries, except 
Russia, which also had the highest age-standardized rate in 2012, 102.7/100,000, followed by Poland, 100.8. 
Decreases between quinquennia were particularly marked in the USA, which also had the lowest rate in 2012 
(60.7/100,000), and in Germany.
Lung cancer
In men, patterns for this cancer site showed increases up to around the 1990s (earlier for Australia and the 
UK, where the rise ended earlier), to decrease thereafter. Age-standardized rates in Argentina fell over the 
whole period (AAPC -0.8) and rates for the USA had a 24.1% decrease since 2002, reaching a rate around 
300/100,000 men in 2012. Poland had the highest rate in 2012, 440.3/100,000 men, followed by Russia, 334.8 
and Italy, 327.0. Age-standardized rates for women were unfavourable in all countries, with the exception of 
the USA. US women had 11.8% decrease since 2002, but still had a high rate in 2012, 193.7/100,000. Women 
in Canada reached the highest rate in 2012 (209.1/100,000, +6.3% since 2002). In Russian women, lung 
cancer rate is the lowest with a value of 39.5 and a decrease of 5.8% since 2002.
Breast cancer
Women from Japan and Poland had increasing age-standardized trends over the whole period (AAPC 2.2 and 
1.2, respectively). Poland had a 6.9% rise between 2002 and 2012 and a rate of 83.6 in 2012. Russia had a 
10.3% rise with a rate of 86.1/100,000 in 2012. Japanese rates in women increased by 33% from 2002 to 
2012, however maintaining the lowest rate in 2012 (37.1/100,000). In the other countries patterns started 
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7to be favourable around the 1990s and continued up to the most recent available year. Consequently, there 
is a systematic levelling of breast cancer age-standardized rates in various areas of the world.
Prostate cancer
North America, Argentina, Australia, and European countries (except Poland) after rises up to around the 
1990s showed stronger decreases in age-standardized rates. Poland and Russia had overall unfavourable 
trends with corresponding high rates in 2012. An increase of 37.3% was registered for Russian men between 
2002 and 2012. Japan showed the lowest rates over the whole period with decreasing rates between 2002 
and 2012 (-9.8%), reaching 61.6/100,000 men in 2012.
Discussion
The present analysis shows that cancer mortality patterns have been decreasing among the elderly in the 
last few decades, even there are substantial differences between countries worldwide. Liver, pancreas, 
kidney and, in women, lung and uterus displayed less favourable trends. Central and eastern European 
countries, particularly Poland and Russia, tended to have less favourable trends in rates.
We selected 11 countries worldwide with long-term valid cancer death certification data. Still, some steep 
variation, likely due to changes in the adoption of subsequent ICD revisions and related coding instructions, 
are apparent (Japan, around 1995; Italy, around 1975).
Overall, mortality rates in women were lower than in men. Different smoking patterns in the past in the two 
sexes play a key role on trends of tobacco-related cancers [14, 15]. However, differences in dietary patterns, 
alcohol consumption, lifestyle habits, as well as occupational exposure probably influence the more 
favourable rates in women. However, declines in most recent periods were in general more marked in men. 
The less favourable trends in eastern Europe could be due to delays in therapeutic advancement adoption, 
unfavourable smoking habits, and dietary habits and other lifestyle factors [16, 17].
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8Trends for lung (and other tobacco-related) cancers reflect different smoking patterns in the two sexes [14]. 
Since the 2000s, the epidemic of lung cancer in men started to level off in most European countries, and to 
appreciably decline in North America and in the UK [4]. This is due to the declines in smoking prevalence over 
generations of men. In contrast, the prevalence of smoking in women increased during or after the Second 
World War in the UK and USA, and in the 1970s in most other countries, i.e. in generation born between the 
1930s and 1950s [18] and middle aged and elderly men tended to quit smoking more than women. Thus, 
lung cancer rates in women are still upwards in various areas of the world [19]. This highlights the need of 
further improvements in tobacco control, particularly in women.
Changing tobacco habits across generations also partly explains trends in other major tobacco-related 
cancers, i.e. head and neck and esophagus. For these neoplasms, the major decreases registered in France 
and Italy also reflect the substantial declines in alcohol drinking among men in those countries [20, 21].
Among other strongly tobacco-related cancers, trends are favourable also for bladder, but not for pancreas, 
which did not show favourable trends among most considered countries, in the elderly as likely in middle 
aged population [22, 23]. The reason for the unfavourable trends for pancreatic cancer remains, however, 
largely undefined [24].
Over the last three decades, improvements in breast cancer management (screening, early diagnosis and 
mainly treatment) favourably influenced the worldwide mortality trends [25-27]. Downward trends were 
observed in elderly women, even if less marked compared to younger ages [26]. At elderly ages, 
characteristics of this neoplasm are different and comorbidities could make undergoing therapies and 
surgeries difficult for these patients. Rises in incidence in Asian countries [28] could explain the increasing 
trend in Japan, which however started from the lowest rates. Increasing trends in Poland and Russia indicate 
the need to improve breast cancer management in those countries.
The favourable trends for stomach cancer in both sexes is probably due to the lower prevalence in 
Helicobacter Pylori infection across generations, more affluent and healthy diet, better food conservation 
and more hygienic food handling, as well as reduced prevalence of tobacco use in men [29, 30]. The 
comparatively high rates in Japan, eastern Europe and Italy call for intervention on these risk factors.
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9Improvements in management of colorectal cancer, in particular in screening and removal of adenomas, have 
positively influenced incidence and mortality for this neoplasm [31]. Besides baseline incidence, related to 
nutrition, diet and other lifestyle factors, variability across countries could be explained by different access 
in treatments and different patterns in risk factors [32].
Liver cancer is a common site of metastasis, and often cirrhosis and chronic hepatitis are recognized as causes 
of deaths instead of the tumour itself, for these reasons liver cancer is difficult to correctly diagnose. 
However, besides the inaccuracies and the effect of changes in criteria of cancer deaths classifications, 
mortality trends from liver cancer also reflect the different impact of hepatitis and alcohol consumption 
worldwide. In Japan, where rates have risen in the past [33], control of HCV is probably the main determinant 
of the decline in rates. In North America, the prevalence of hepatitis C has increased, while in Italy, both HBV 
and HCV, have been declining. Newer antiviral treatment of HCV are likely to favourable affect future liver 
cancer trends. Rises in rates in Germany and the UK, and decreases in France, likely reflect the different 
patterns in alcohol consumption and the rise of obesity, too [34].
The favourable trends in ovarian cancer in North America, the UK and few other European countries have 
been partly or largely attributed to the use of oral contraceptives and the cessation of hormone replacement 
therapy use following the Women’s Health Initiative report in 2002 [35], which in those countries became 
common in women born since 1930’s [36].
The decrease in uterine cancer mortality are due to decreases in cervical cancer rates following the adoption 
of the Pap smear test. However, WHO data does not allow distinguish between cervix and corpus uteri and 
hence interpretation of the levelling of rates among considered countries is limited.
After early rises due to better diagnosis and certification, mortality for lymphomas, multiple myeloma and 
leukemia has levelled off in most countries over the recent decades. This reflects some impact in improved 
treatment of lymphoid neoplasms, in the elderly too [37, 38].
Cancer management in elderly populations is a challenge. Changes in criteria for cancer death diagnosis and 
inaccuracy in coding and classification, in particular for this age group, likely have affected mortality and 
incidence trends over time. However, quantifying the consequences of uncertainties in cancer death 
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10
certifications on observed changes in rates remains difficult. Recently, improvements in early diagnosis and 
cancer death classification have influenced incidence data, but their role on mortality trends is still 
controversial due to the complex and heterogeneous health conditions in the elderly (comorbidities, multiple 
drug use, etc.). Therefore, difficulties in cancer care for older persons and their frailty caused their exclusion 
from clinical trials and a paucity of data on cancer management in the literature.
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Figure legends
Figure 1a. Joinpoint analysis of age-standardized (world standard population) mortality rates for all 
neoplasms, oral cavity and pharynx, and esophagus cancer in men (full triangles) and women (empty circles) 
aged 65+, in 11 major countries worldwide, 1970–2015.
Figure 1b. Joinpoint analysis of age-standardized (world standard population) mortality rates for stomach, 
colorectum, and liver cancer in men (full triangles) and women (empty circles) aged 65+, in 11 major countries 
worldwide, 1970–2015.
Figure 1c. Joinpoint analysis of age-standardized (world standard population) mortality rates for pancreas, 
larynx, and lung cancer in men (full triangles) and women (empty circles) aged 65+, in 11 major countries 
worldwide, 1970–2015.
Figure 1d. Joinpoint analysis of age-standardized (world standard population) mortality rates for breast, 
uterus (cervix and corpus) and ovary cancer in men (full triangles) and women (empty circles) aged 65+, in 
11 major countries worldwide, 1970–2015.
Figure 1e. Joinpoint analysis of age-standardized (world standard population) mortality rates for prostate, 
bladder, and kidney cancer in men (full triangles) and women (empty circles) aged 65+, in 11 major countries 
worldwide, 1970–2015.
Figure 1f. Joinpoint analysis of age-standardized (world standard population) mortality rates for non-Hodgkin 
lymphoma, multiple myeloma, and leukemia cancer in men (full triangles) and women (empty circles) aged 
65+, in 11 major countries worldwide, 1970–2015.
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Table 1. Trends in age-standardized (65+ years, world standard population) deaths certification rates per 100,000 men from all 
cancers and 14 major cancer sites in the USA, Canada, Argentina, Japan, Australia, the UK, Germany, France, Italy, Poland and the 
Russian Federation between 2000-2004 and 2010-2014 (unless indicated in parentheses) along with corresponding percent changes 
between quinquennia.
Age-standardized mortality rates (world standard population)
CANCER
USA
Canada 
(2010-2013) Argentina Japan Australia UK Germany France Italy Poland
Russian 
Federation 
(2010-2013)
2000-2004 1219.65 1320.34 1187.17 1340.02 1271.93 1388.13 1324.51 1441.75 1467.28 1663.65 1361.59
2010-2014 1014.58 1103.43 1089.11 1164.20 1096.48 1217.35 1152.00 1187.60 1251.95 1517.82 1295.39
ALL CANCERS
% change (2012/2002) -16.8 -16.4 -8.3 -13.1 -13.8 -12.3 -13.0 -17.6 -14.7 -8.8 -4.9
2000-2004 17.05 21.33 17.19 22.76 23.11 15.94 24.03 39.21 25.42 27.26 42.96
2010-2014 16.62 19.57 16.60 25.59 20.13 19.29 27.74 29.91 21.02 31.85 42.66
ORAL CAVITY AND PHARYNX
% change (2012/2002) -2.5 -8.2 -3.5 12.4 -12.9 21.0 15.5 -23.7 -17.3 16.8 -0.7
2000-2004 37.59 37.02 53.17 57.92 40.33 72.17 30.52 46.90 21.34 29.44 42.55
2010-2014 35.42 35.98 42.41 53.00 36.26 70.08 33.77 35.97 16.38 25.89 37.62
ESOPHAGUS
% change (2012/2002) -5.8 -2.8 -20.2 -8.5 -10.1 -2.9 10.6 -23.3 -23.2 -12.1 -11.6
2000-2004 28.33 43.75 75.70 229.40 44.45 68.86 79.68 52.08 101.49 128.36 211.69
2010-2014 20.07 30.29 59.95 171.83 30.77 42.36 51.00 38.19 71.47 95.10 160.74
STOMACH
% change (2012/2002) -29.2 -30.8 -20.8 -25.1 -30.8 -38.5 -36.0 -26.7 -29.6 -25.9 -24.1
2000-2004 120.73 169.60 138.26 149.96 163.24 170.37 181.10 169.81 171.01 186.05 168.68
2010-2014 86.49 139.46 140.78 137.60 130.57 147.16 138.67 137.08 149.10 199.51 173.94
COLORECTUM
% change (2012/2002) -28.4 -17.8 1.8 -8.2 -20.0 -13.6 -23.4 -19.3 -12.8 7.2 3.1
2000-2004 20.04 21.51 2.69 162.93 26.56 20.01 30.23 65.33 54.09 2.76 39.40
2010-2014 24.48 32.00 5.93 105.16 33.17 33.49 39.22 63.06 52.04 8.72 39.01
LIVER
% change (2012/2002) 22.2 48.8 120.1 -35.5 24.9 67.4 29.8 -3.5 -3.8 216.0 -1.0
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Age-standardized mortality rates (world standard population)
CANCER
USA
Canada 
(2010-2013) Argentina Japan Australia UK Germany France Italy Poland
Russian 
Federation 
(2010-2013)
2000-2004 60.43 59.01 63.13 73.86 54.50 54.70 67.80 61.21 62.23 58.02 54.73
2010-2014 63.02 57.22 63.34 81.01 56.77 58.39 74.35 67.13 66.98 60.46 61.29
PANCREAS
% change (2012/2002) 4.3 -3.0 0.3 9.7 4.2 6.7 9.7 9.7 7.6 4.2 12.0
2000-2004 11.58 14.66 27.31 6.96 12.09 10.33 12.36 19.78 24.93 36.45 37.32
2010-2014 9.11 8.86 22.00 4.90 8.60 8.94 11.00 11.38 17.32 29.62 29.15
LARYNX
% change (2012/2002) -21.3 -39.6 -19.4 -29.5 -28.9 -13.5 -11.0 -42.5 -30.5 -18.7 -21.9
2000-2004 394.56 388.44 230.92 305.00 287.60 352.26 326.32 305.71 403.20 517.30 394.78
2010-2014 299.47 315.01 212.62 278.25 228.68 285.68 273.26 274.17 326.99 440.30 334.80
LUNG
% change (2012/2002) -24.1 -18.9 -7.9 -8.8 -20.5 -18.9 -16.3 -10.3 -18.9 -14.9 -15.2
2000-2004 143.82 162.05 185.59 68.26 192.78 191.12 168.95 180.56 129.14 158.19 95.00
2010-2014 103.30 116.04 160.00 61.57 154.23 163.91 139.95 123.54 96.63 148.30 130.43
PROSTATE
% change (2012/2002) -28.2 -28.4 -13.8 -9.8 -20.0 -14.2 -17.2 -31.6 -25.2 -6.3 37.3
2000-2004 38.68 45.17 44.44 27.89 41.13 60.12 51.58 60.76 70.44 85.91 67.96
2010-2014 38.75 42.89 39.45 26.88 34.84 51.11 38.91 54.01 57.91 83.73 57.73
BLADDER
% change (2012/2002) 0.2 -5.0 -11.2 -3.6 -15.3 -15.0 -24.6 -11.1 -17.8 -2.5 -15.0
2000-2004 30.04 31.17 34.55 24.18 28.70 31.91 47.66 38.36 31.82 46.32 .
2010-2014 29.02 31.51 38.61 27.77 29.18 34.37 51.74 41.49 34.22 45.47 .
KIDNEY
% change (2012/2002) -3.4 1.1 11.7 14.9 1.6 7.7 8.6 8.1 7.6 -1.8 .
2000-2004 46.19 47.07 24.21 31.52 45.11 36.99 30.64 36.60 34.26 22.64 10.46
2010-2014 36.90 38.77 20.44 30.68 37.11 34.65 31.21 32.55 30.72 22.00 13.82
NON-HODGKIN LYMPHOMA
% change (2012/2002) -20.1 -17.6 -15.6 -2.7 -17.7 -6.3 1.9 -11.1 -10.3 -2.8 32.1
2000-2004 25.44 24.96 10.45 13.73 25.77 23.67 22.37 24.11 22.02 15.62 5.37
2010-2014 22.95 22.75 10.32 11.35 23.46 22.31 13.56 21.02 21.71 17.18 6.88
MULTIPLE MYELOMA
% change (2012/2002) -9.8 -8.8 -1.2 -17.3 -9.0 -5.7 -39.4 -12.8 -1.4 10.0 28.3
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Age-standardized mortality rates (world standard population)
CANCER
USA
Canada 
(2010-2013) Argentina Japan Australia UK Germany France Italy Poland
Russian 
Federation 
(2010-2013)
2000-2004 47.88 45.22 27.42 23.56 45.41 36.97 42.32 46.53 43.57 41.47 28.48
2010-2014 43.77 41.12 24.95 23.30 43.10 37.12 39.33 42.68 40.11 42.34 26.66
LEUKEMIA
% change (2012/2002) -8.6 -9.1 -9.0 -1.1 -5.1 0.4 -7.1 -8.3 -7.9 2.1 -6.4
Table 2. Trends in age-standardized (65+ years, world standard population) deaths certification rates per 100,000 women from all 
cancers and 16 major cancer sites in the USA, Canada, Argentina, Japan, Australia, the UK, Germany, France, Italy, Poland and the 
Russian Federation between 2000-2004 and 2010-2014 (unless indicated in parentheses) along with corresponding percent changes 
between quinquennia.
Age-standardized mortality rates (world standard population)
CANCER
USA
Canada 
(2010-2013) Argentina Japan Australia UK Germany France Italy Poland
Russian 
Federation 
(2010-2013)
2000-2004 792.80 815.01 635.09 560.88 704.72 861.44 730.75 633.73 691.48 760.68 588.71
2010-2014 690.28 752.54 591.35 506.92 649.31 803.98 677.25 577.02 643.49 741.55 580.50
ALL CANCERS
% change (2012/2002) -12.9 -7.7 -6.9 -9.6 -7.9 -6.7 -7.3 -8.9 -6.9 -2.5 -1.4
2000-2004 7.19 8.79 5.09 6.59 8.03 7.22 5.89 6.18 6.36 6.54 7.07
2010-2014 5.92 7.40 5.02 6.36 7.15 7.76 8.05 6.01 6.84 8.48 6.50
ORAL CAVITY AND PHARYNX
% change (2012/2002) -17.6 -15.8 -1.4 -3.5 -11.0 7.4 36.7 -2.8 7.6 29.6 -8.1
2000-2004 9.17 10.63 16.36 7.34 15.11 30.90 6.77 7.37 4.62 5.66 9.55
2010-2014 7.41 9.23 13.00 6.74 11.81 26.29 8.05 6.88 3.79 5.07 6.58
ESOPHAGUS
% change (2012/2002) -19.3 -13.2 -20.5 -8.2 -21.8 -14.9 19.0 -6.7 -17.9 -10.5 -31.1
2000-2004 14.15 19.62 26.98 77.26 19.00 28.44 41.05 20.25 46.56 45.99 88.60
2010-2014 10.21 14.61 21.88 55.19 13.81 17.64 26.09 13.80 33.45 32.19 65.99
STOMACH
% change (2012/2002) -27.8 -25.6 -18.9 -28.6 -27.3 -38.0 -36.5 -31.8 -28.2 -30.0 -25.5
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Age-standardized mortality rates (world standard population)
CANCER
USA
Canada 
(2010-2013) Argentina Japan Australia UK Germany France Italy Poland
Russian 
Federation 
(2010-2013)
2000-2004 84.25 106.86 82.16 81.46 106.56 103.56 115.61 93.96 98.05 107.81 101.19
2010-2014 60.71 90.25 75.47 74.66 83.33 92.09 83.02 76.07 84.53 100.84 102.65
COLORECTUM
% change (2012/2002) -27.9 -15.5 -8.1 -8.3 -21.8 -11.1 -28.2 -19.0 -13.8 -6.5 1.4
2000-2004 9.13 9.22 1.51 59.62 10.46 10.43 10.77 13.99 19.32 1.68 17.82
2010-2014 11.33 15.62 2.67 39.52 16.26 17.84 13.56 16.23 19.04 4.61 18.11
LIVER
% change (2012/2002) 24.1 69.5 76.8 -33.7 55.5 71.1 25.9 16.0 -1.4 173.9 1.6
2000-2004 48.34 47.67 48.02 46.08 42.54 43.37 50.77 40.36 46.90 41.97 33.48
2010-2014 49.37 48.04 47.97 53.61 44.94 47.20 57.71 45.73 50.97 43.73 38.64
PANCREAS
% change (2012/2002) 2.1 0.8 -0.1 16.3 5.6 8.8 13.7 13.3 8.7 4.2 15.4
2000-2004 2.45 2.77 2.42 0.38 1.54 1.99 1.17 1.30 1.51 2.51 1.09
2010-2014 1.83 1.80 2.56 0.27 1.09 1.85 1.40 0.98 1.49 2.57 0.95
LARYNX
% change (2012/2002) -25.2 -34.9 5.7 -28.0 -29.2 -7.2 20.0 -24.7 -1.2 2.6 -12.8
2000-2004 219.52 196.70 44.74 72.05 114.53 170.86 72.88 47.22 65.82 81.35 41.98
2010-2014 193.68 209.13 59.99 72.87 122.49 183.85 97.87 65.48 77.52 111.50 39.53
LUNG
% change (2012/2002) -11.8 6.3 34.1 1.1 7.0 7.6 34.3 38.7 17.8 37.1 -5.8
2000-2004 99.95 109.80 115.42 27.90 90.34 121.76 112.03 103.76 98.97 78.18 78.00
2010-2014 85.42 90.60 104.01 37.11 83.43 101.08 108.72 95.60 92.06 83.60 86.07
BREAST
% change (2012/2002) -14.5 -17.5 -9.9 33.0 -7.7 -17.0 -3.0 -7.9 -7.0 6.9 10.3
2000-2004 27.35 24.72 43.65 19.65 21.78 28.39 29.43 29.46 26.01 49.95 48.32
2010-2014 28.46 25.81 38.91 17.67 20.43 29.70 24.33 28.75 24.23 47.65 44.68
UTERUS (CERVIX AND CORPUS)
% change (2012/2002) 4.1 4.4 -10.9 -10.0 -6.2 4.6 -17.3 -2.4 -6.9 -4.6 -7.5
2000-2004 41.81 38.66 23.95 14.77 34.73 51.72 43.11 35.55 28.22 36.16 28.22
2010-2014 35.50 35.70 23.07 14.36 32.86 45.29 38.61 33.04 27.94 39.63 27.74
OVARY
% change (2012/2002) -15.1 -7.6 -3.7 -2.8 -5.4 -12.4 -10.4 -7.1 -1.0 9.6 -1.7
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Age-standardized mortality rates (world standard population)
CANCER
USA
Canada 
(2010-2013) Argentina Japan Australia UK Germany France Italy Poland
Russian 
Federation 
(2010-2013)
2000-2004 11.87 12.54 8.61 7.61 12.72 19.76 15.05 11.28 11.00 12.25 8.14
2010-2014 11.09 11.97 8.02 7.11 10.56 17.19 11.38 9.81 9.98 12.55 7.06
BLADDER
% change (2012/2002) -6.6 -4.5 -6.9 -6.7 -17.0 -13.0 -24.4 -13.0 -9.2 2.4 -13.2
2000-2004 14.52 14.86 11.72 9.18 17.46 15.55 21.12 13.95 11.93 20.23 .
2010-2014 12.91 14.96 12.87 9.97 14.43 16.84 21.06 14.00 12.17 19.76 .
KIDNEY
% change (2012/2002) -11.1 0.7 9.8 8.6 -17.3 8.3 -0.3 0.4 2.0 -2.3 .
2000-2004 30.76 32.41 15.64 16.08 32.09 25.44 20.41 22.92 23.41 13.20 5.79
2010-2014 23.26 26.13 12.26 16.25 21.00 22.94 19.70 18.32 19.02 14.14 8.07
NON-HODGKIN LYMPHOMA
% change (2012/2002) -24.4 -19.4 -21.6 1.0 -34.6 -9.8 -3.5 -20.1 -18.8 7.1 39.2
2000-2004 17.38 17.15 8.35 9.17 16.33 15.97 15.50 15.82 15.57 12.28 4.36
2010-2014 14.84 14.46 7.44 7.54 14.76 14.70 8.99 13.15 15.10 12.91 5.91
MULTIPLE MYELOMA
% change (2012/2002) -14.6 -15.7 -11.0 -17.8 -9.6 -7.9 -42.0 -16.9 -3.0 5.1 35.6
2000-2004 25.72 23.35 15.95 11.78 24.61 20.24 23.98 24.89 23.58 22.53 15.22
2010-2014 23.41 22.96 13.22 11.27 23.70 20.21 22.34 22.80 22.36 21.58 14.65
LEUKEMIA
% change (2012/2002) -9.0 -1.7 -17.1 -4.3 -3.7 -0.1 -6.9 -8.4 -5.2 -4.2 -3.7
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 Figure 1a. Joinpoint analysis of age-standardized (world standard population) mortality rates for all 
neoplasms, oral cavity and pharynx, and esophagus cancer in men (full triangles) and women (empty 
circles) aged 65+, in 11 major countries worldwide, 1970–2015. 
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 Figure 1b. Joinpoint analysis of age-standardized (world standard population) mortality rates for stomach, 
colorectum, and liver cancer in men (full triangles) and women (empty circles) aged 65+, in 11 major 
countries worldwide, 1970–2015. 
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 Figure 1c. Joinpoint analysis of age-standardized (world standard population) mortality rates for pancreas, 
larynx, and lung cancer in men (full triangles) and women (empty circles) aged 65+, in 11 major countries 
worldwide, 1970–2015. 
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 Figure 1d. Joinpoint analysis of age-standardized (world standard population) mortality rates for breast, 
uterus (cervix and corpus) and ovary cancer in men (full triangles) and women (empty circles) aged 65+, in 
11 major countries worldwide, 1970–2015. 
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 Figure 1e. Joinpoint analysis of age-standardized (world standard population) mortality rates for prostate, 
bladder, and kidney cancer in men (full triangles) and women (empty circles) aged 65+, in 11 major 
countries worldwide, 1970–2015. 
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 Figure 1f. Joinpoint analysis of age-standardized (world standard population) mortality rates for non-
Hodgkin lymphoma, multiple myeloma, and leukemia cancer in men (full triangles) and women (empty 
circles) aged 65+, in 11 major countries worldwide, 1970–2015. 
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